New hope for advanced breast cancer: testing four powerful drug combos

NCT ID NCT05508906

Summary

This early-stage study aims to find safe and effective doses for a new breast cancer drug, palazestrant, when combined with four different existing cancer drugs. It will enroll about 190 adults with advanced or metastatic ER-positive, HER2-negative breast cancer who have had limited prior hormone therapy. The main goals are to determine the safest doses and see how the body processes these drug combinations.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Advent Health Hematology and Oncology

    RECRUITING

    Orlando, Florida, 32804, United States

    Contact

  • Atrium Health Levine Cancer Institute

    RECRUITING

    Charlotte, North Carolina, 28204, United States

    Contact

  • Banner MD Anderson Cancer Center

    RECRUITING

    Gilbert, Arizona, 85234, United States

    Contact

  • Breast Cancer Research Center- Western Australia

    RECRUITING

    Nedlands, Western Australia, 6009, Australia

    Contact

  • Dana Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

    Contact

  • Henry Ford Health

    RECRUITING

    Detroit, Michigan, 48126, United States

    Contact

  • Henry-Joyce Cancer Clinic, The Vanderbilt Clinic

    RECRUITING

    Nashville, Tennessee, 37232, United States

    Contact

  • Ichan School of Medicine at Mount Sinai

    RECRUITING

    New York, New York, 10029, United States

    Contact

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact

  • Macquarie Health

    RECRUITING

    Sydney, New South Wales, 2109, Australia

    Contact

  • Northwest Medical Specialties

    RECRUITING

    Tacoma, Washington, 98405, United States

    Contact

  • Regents of the University of Minnesota

    RECRUITING

    Minneapolis, Minnesota, 55455, United States

    Contact

  • University of California San Francisco Health

    RECRUITING

    San Francisco, California, 94158, United States

    Contact

  • University of Colorado Cancer Center

    RECRUITING

    Aurora, Colorado, 80045, United States

    Contact

  • University of Iowa

    RECRUITING

    Iowa City, Iowa, 52242, United States

    Contact

  • Washington University, School of Medicine

    RECRUITING

    St Louis, Missouri, 63110, United States

    Contact

Conditions

Explore the condition pages connected to this study.